Group 1 - GuanZe Medical (02427) resumed trading with a high opening, increasing by 15.38% to HKD 1.8, with a trading volume of HKD 2.106 million [1] - The company announced that the offeror, Fude (Hong Kong) Investment, intends to acquire approximately 699 million shares from the controlling shareholder, representing about 73.6% of the total issued share capital, for a total consideration of approximately HKD 175 million [1] - Following the completion of the acquisition, the offeror and concert parties are required to make an unconditional cash offer to acquire all issued shares of the company at a cash offer price of HKD 0.25 per share, which represents a discount of approximately 84% compared to the closing price of HKD 1.56 before the suspension [1]
GUANZE MEDICAL复牌高开逾15% 获富德(香港)投资控股折让约84%提全购要约